FindTrial
Sign In

Comparison of SurePath® and ThinPrep® liquid-based cytology in endoscopic ultrasound-guided fine needle aspiration of pancreatic lesion

Comparison of SurePath® and ThinPrep® liquid-based cytology in endoscopic ultrasound-guided fine needle aspiration of pancreatic lesion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006748
Enrollment
92
Registered
2021-11-11
Start date
2021-11-05
Completion date
Unknown
Last updated
2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Gangnam Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) A person suspected of pancreatic malignancy through imaging tests (CT, MRI, PET-CT). 2) Those who need to perform endoscopic ultrasound-guided fine needle aspiration.

Exclusion criteria

Exclusion criteria: 1) Those who are vulnerable, such as minors and illiteracy. 2) Patients who has difficulty accessing endoscopic ultrasound due to chest or abdominal surgery. 3) Patients who refused to participate in the study

Design outcomes

Primary

MeasureTime frame
Comparison the diagnostic performance (accuracy, sensitivity, specificity, positive predictive value, and negative predictive value) between Surepath® and Thinprep—

Secondary

MeasureTime frame
Evaluation of the cytomorphologic features between Surepath® and Thinprep®—

Countries

Korea, Republic of

Contacts

Public ContactMin Young Do

Yonsei University Health System, Gangnam Severance Hospital

decays@naver.com+82-2-2019-3310

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026